Infection with antimicrobial-resistant microorganisms in dialysis patients

Area of Science:

• Infectious Diseases
• Nephrology
• Microbiology

Background:

• Increasing prevalence of antimicrobial-resistant microorganisms in healthcare settings, particularly outpatient dialysis facilities.
• Antimicrobial use and patient-to-patient transmission are key drivers of this rise.
• Commonly isolated resistant organisms include MRSA and VRE, causing significant infections in hemodialysis (HD) and peritoneal dialysis (PD) patients.

Purpose of the Study:

• To highlight the growing problem of antimicrobial resistance in dialysis patients.
• To discuss the impact of antimicrobial use on the emergence of resistance, including vancomycin and mupirocin resistance.
• To emphasize the importance of infection control and appropriate antimicrobial stewardship.

Main Methods:

• Review of current literature and clinical observations regarding antimicrobial resistance patterns in dialysis populations.
• Identification of common resistant pathogens and associated infections (e.g., catheter-related bacteremia, peritonitis).
• Analysis of factors contributing to resistance, such as prophylactic and therapeutic antimicrobial use.

Main Results:

• Significant increase in MRSA and VRE in HD and PD patients.
• Emergence of vancomycin-resistant staphylococci and high-level mupirocin resistance in S. aureus, especially in PD patients using prophylactic mupirocin.
• Newer agents like linezolid and quinupristin/dalfopristin show activity but already face emerging resistance.

Conclusions:

• Appropriate antimicrobial use, including adherence to vancomycin guidelines, is crucial for preserving antibiotic efficacy.
• Preventing transmission of resistant organisms in dialysis facilities is essential.
• Ongoing surveillance and development of new strategies are needed to combat antimicrobial resistance in this vulnerable patient group.